{"DataElement":{"publicId":"5005031","version":"1","preferredName":"Eligibility Criteria Disease Measured by Contrast Enhanced MRI Within 21 Days Start Treatment Indicator","preferredDefinition":"Indicator to signify whether or not the patient has measurable constrast-enchancing disease by MRI within 21 days of starting treatment.","longName":"5005013v1.0:3506068v1.0","context":"ABTC","contextVersion":"1","DataElementConcept":{"publicId":"5005013","version":"1","preferredName":"Eligibility Criteria Disease Measured by Contrast Enhanced MRI Within 21 Days Start Treatment","preferredDefinition":"Characteristics which are necessary to allow a subject to participate in a clinical study, as outlined in the study protocol. The concept covers inclusion and exclusion criteria._Any abnormal condition of the body or mind that causes discomfort, dysfunction, or distress to the person affected or those in contact with the person. The term is often used broadly to include injuries, disabilities, syndromes, symptoms, deviant behaviors, and atypical variations of structure and function._A technique that uses radiofrequency waves and a magnet to image the body.  The images are enhanced by the addition of contrast agents which selectively intensify anatomical regions to intensify the clarity of the image for diagnostic purposes. 2005_Annotation used to indicate the size or magnitude of something that was determined by comparison to a standard._On the inside; contained in._A number with no fractional part, including the negative and positive numbers as well as zero.::21_The time for Earth to make a complete rotation on its axis; ordinarily divided into twenty-four hours, equal to 86 400 seconds. This also refers to a specific day._Have a beginning, in a temporal, spatial, or evaluative sense; the point in space or time where something begins._An action or administration of therapeutic agents to produce an effect that is intended to alter or stop a pathologic process.","longName":"5005011v1.0:3761935v1.0","context":"ABTC","contextVersion":"1","ObjectClass":{"publicId":"5005011","version":"1","preferredName":"Clinical Trial Eligibility Criteria Disease or Disorder","preferredDefinition":"Characteristics which are necessary to allow a subject to participate in a clinical study, as outlined in the study protocol. The concept covers inclusion and exclusion criteria.:Any abnormal condition of the body or mind that causes discomfort, dysfunction, or distress to the person affected or those in contact with the person. The term is often used broadly to include injuries, disabilities, syndromes, symptoms, deviant behaviors, and atypical variations of structure and function.","longName":"C16112:C2991","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Clinical Trial Eligibility Criteria","conceptCode":"C16112","definition":"Characteristics which are necessary to allow a subject to participate in a clinical study, as outlined in the study protocol. The concept covers inclusion and exclusion criteria.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Disease or Disorder","conceptCode":"C2991","definition":"Any abnormal condition of the body or mind that causes discomfort, dysfunction, or distress to the person affected or those in contact with the person. The term is often used broadly to include injuries, disabilities, syndromes, symptoms, deviant behaviors, and atypical variations of structure and function.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"1F669A0D-780A-DBEB-E050-BB89AD4354E7","latestVersionIndicator":"Yes","beginDate":"2015-09-10","endDate":null,"createdBy":"COOPERM","dateCreated":"2015-09-10","modifiedBy":"ONEDATA","dateModified":"2015-09-10","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"3761935","version":"1","preferredName":"Contrast-enhanced Magnetic Resonance Imaging Measurement Within Integer::21 Day Begin Therapeutic Procedure","preferredDefinition":"A technique that uses radiofrequency waves and a magnet to image the body.  The images are enhanced by the addition of contrast agents which selectively intensify anatomical regions to intensify the clarity of the image for diagnostic purposes. 2005:Annotation used to indicate the size or magnitude of something that was determined by comparison to a standard.:On the inside; contained in.:A number with no fractional part, including the negative and positive numbers as well as zero.::21:The time for Earth to make a complete rotation on its axis; ordinarily divided into twenty-four hours, equal to 86 400 seconds. This also refers to a specific day.       :Have a beginning, in a temporal, spatial, or evaluative sense.:An action or administration of therapeutic agents to produce an effect that is intended to alter the course of a pathologic process.","longName":"3761935v1.0","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Contrast-enhanced Magnetic Resonance Imaging","conceptCode":"C46087","definition":"A technique that uses radiofrequency waves and a magnet to image the body.  The images are enhanced by the addition of contrast agents which selectively intensify anatomical regions to intensify the clarity of the image for diagnostic purposes. 2005","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"6"},{"longName":"Measurement","conceptCode":"C25209","definition":"Annotation used to indicate the size or magnitude of something that was determined by comparison to a standard.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"5"},{"longName":"Within","conceptCode":"C25282","definition":"On the inside; contained in.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"4"},{"longName":"Integer","conceptCode":"C45255","definition":"A number with no fractional part, including the negative and positive numbers as well as zero.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Day","conceptCode":"C25301","definition":"The time for Earth to make a complete rotation on its axis; ordinarily divided into twenty-four hours, equal to 86 400 seconds. This also refers to a specific day.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Begin","conceptCode":"C25431","definition":"Have a beginning, in a temporal, spatial, or evaluative sense; the point in space or time where something begins.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Therapeutic Procedure","conceptCode":"C49236","definition":"An action or administration of therapeutic agents to produce an effect that is intended to alter or stop a pathologic process.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"DCAFF9E9-8D88-2897-E040-BB89AD4348B0","latestVersionIndicator":"Yes","beginDate":"2013-05-14","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-05-14","modifiedBy":"ONEDATA","dateModified":"2013-05-14","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008525","version":"1","preferredName":"Eligibility","preferredDefinition":"trial-specific criteria that a patient must meet to be enrolled.","longName":"ELIG","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B1EC3968-9F25-305A-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-16","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-16","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"1F669A0D-7818-DBEB-E050-BB89AD4354E7","latestVersionIndicator":"Yes","beginDate":"2015-09-10","endDate":null,"createdBy":"COOPERM","dateCreated":"2015-09-10","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":"Created for ABTC eligibility checklist for 1401 study per request by J.Zhao. mc 9/10/15","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"3506068","version":"1","preferredName":"Yes No Indicator","preferredDefinition":"The preferred Value Domain to indicate a question with permissible values of yes/no.","longName":"YES_NO_IND","context":"NCI Standards","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":"2","maxLength":"3","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"No","valueDescription":"No","ValueMeaning":{"publicId":"3197154","version":"1","preferredName":"No","longName":"3197154","preferredDefinition":"The non-affirmative response to a question.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"No","conceptCode":"C49487","definition":"The non-affirmative response to a question.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9D865DE5-55AD-1AC9-E040-BB89AD436B4F","latestVersionIndicator":"Yes","beginDate":"2011-03-02","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2011-03-02","modifiedBy":"SOKKERL","dateModified":"2023-12-05","changeDescription":null,"administrativeNotes":"2022.12.28 Alt VM added per ticket request CADSR0001837. aj","unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"C37A1BEB-75C2-B6C9-E040-BB89AD434179","beginDate":"2012-06-27","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2012-06-27","modifiedBy":"ONEDATA","dateModified":"2012-06-27","deletedIndicator":"No"},{"value":"Yes","valueDescription":"Yes","ValueMeaning":{"publicId":"3197153","version":"1","preferredName":"Yes","longName":"3197153v1.00","preferredDefinition":"The affirmative response to a question.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Yes","conceptCode":"C49488","definition":"The affirmative response to a question.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9D865DE5-558A-1AC9-E040-BB89AD436B4F","latestVersionIndicator":"Yes","beginDate":"2011-03-02","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2011-03-02","modifiedBy":"SOKKERL","dateModified":"2023-12-05","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"C37A1BEB-75CC-B6C9-E040-BB89AD434179","beginDate":"2012-06-27","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2012-06-27","modifiedBy":"ONEDATA","dateModified":"2012-06-27","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"3502157","version":"1","preferredName":"Yes No Indicator Value Domains","preferredDefinition":"Conceptual domain that includes value meanings to be used for Indicator Value Meanings such as Yes, No, Unknown, No Applicable","longName":"YES_NO_IND_VD","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"C377DE0C-8C3E-DCA8-E040-BB89AD431B6D","latestVersionIndicator":"Yes","beginDate":"2012-06-27","endDate":null,"createdBy":"CURTIST","dateCreated":"2012-06-27","modifiedBy":"CURTIST","dateModified":"2012-06-27","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2421125","version":"1","preferredName":"Ind-2","preferredDefinition":"A caDSR representation term that is used to indicate a question with permissible values of yes/no","longName":"C38147","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Yes or No Response","conceptCode":"C38147","definition":"A response or indicator that can have a value of either yes or no.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RETIRED ARCHIVED","registrationStatus":"Retired","id":"0303DF01-F4B4-15EC-E044-0003BA3F9857","latestVersionIndicator":"No","beginDate":"2005-10-18","endDate":"2016-04-27","createdBy":"SHIDED","dateCreated":"2005-10-18","modifiedBy":"TAYLORT","dateModified":"2020-10-03","changeDescription":"10.3.20 TL changed WFS from RETIRED PHASED OUT to RETIRED ARCHIVED. Changed Workflow Status DBW 04-27-2016","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Standard","id":"C37A1BEB-75AE-B6C9-E040-BB89AD434179","latestVersionIndicator":"Yes","beginDate":"2012-06-27","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2012-06-27","modifiedBy":"TSESU","dateModified":"2023-08-16","changeDescription":"8/29/17 tt added CSI per Round 5 finalization task. 3/12/17 jk added Standard reg status; ownership transfered from CTEP to NCI Standards with concurrence of CTEP/Brian Campbell. jk","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"4280691","version":"1","longName":"CRF CDEs","context":"ABTC","ClassificationSchemeItems":[{"publicId":"4280724","version":"1","longName":"Eligibility Checklist","context":"ABTC"}]}],"AlternateNames":[],"ReferenceDocuments":[{"name":"Does the patient have measura","type":"Preferred Question Text","description":"Does the patient have measurable contrast-enhancing disease by MRI within 21 days of starting treatment?","url":null,"context":"ABTC"},{"name":"ABTC-1602 Question","type":"Alternate Question Text","description":"Does the patient have measurable (defined by at least 1 cm x 1 cm) contrast-enhancing disease by MRI imaging within 21 days of starting treatment?","url":null,"context":"ABTC"},{"name":"ABTC-1501 Question","type":"Alternate Question Text","description":"Does the patient have measurable contrast-enhancing disease (defined as at least 1 cm x 1 cm) by MRI imaging within 21 days prior to starting treatment (patients may have gross total resection, but should have measurable disease post-operatively)?","url":null,"context":"ABTC"},{"name":"ABTC 1804 Text 1","type":"Alternate Question Text","description":"Does the patient have measurable contrast-enhancing disease by MRI within 7-14 days of starting treatment?","url":null,"context":"ABTC"},{"name":"ABTC 1802 Text 1","type":"Alternate Question Text","description":"Does the patient have measurable contrast-enhancing disease by MRI within 30 days of starting treatment?","url":null,"context":"ABTC"},{"name":"ABTC 1804 Text 2","type":"Alternate Question Text","description":"Would the patient be able to have a research scan within 21 days of prestudy MRI?","url":null,"context":"ABTC"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"1F669A0D-7830-DBEB-E050-BB89AD4354E7","latestVersionIndicator":"Yes","beginDate":"2015-09-10","endDate":null,"createdBy":"COOPERM","dateCreated":"2015-09-10","modifiedBy":"TSESU","dateModified":"2020-08-13","changeDescription":"Created for ABTC eligibility checklist for 1401 study per request by J.Zhao. mc 9/10/15","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}